Is cytokine from adipose tissue associated with metabolic syndrome?

脂肪组织中的细胞因子与代谢综合征有关吗?

基本信息

  • 批准号:
    18590621
  • 负责人:
  • 金额:
    $ 2.57万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

The relationships between plasma concentrations of monocyte chemoattractant protein-1 (MCP-1), hepatocyte growth factor (HGF), plasminogen activator ihhibitor-1 (PAI-1) and TNF-α and the metabolic syndrome were examined in a Japanese general population. In 1999, we conducted a health examination in 1,492 subjects, aged 40 years or older in a farming community, Tanushimaru, Fukuoka, Japan. We measured HGF and PAI-1 in addition to conventional risk factors. We also performed a health examination in 842 subjects in a fishing community, Uku Island, Nagasaki, Japan in 2004-2007. We measured adipocytekine such as MCP-1, PAI-1, and TNF-α. With multiple linear regression analysis after adjustments for age, sex, and confounders, MCP-1 and PAI-1 were significantly related to insulin resistance, and also HGF and TNF-α were associated with the component of the metabolic syndrome. HGF and TNF-α levels were higher (p<0.05) in proportion to the accumulation of the number of the metabolic syndrome. In conclusion, our results indicate that serum HGF and TNF-α are strongly associated with the metabolic syndrome. It is very interesting that comparing the strength of associations between adipocytekine and the metabolic syndrome in different districts (farming and fishing areas). A longitudinal epidemiological survey may be needed to be clarified the area difference between them in the near future.
对日本普通人群血浆单核细胞趋化蛋白-1、肝细胞生长因子、纤溶酶原激活物抑制物-1和肿瘤坏死因子-α水平与代谢综合征的关系进行了研究。1999年,我们在日本福冈谷岛丸的一个农业社区对1,492名年龄在40岁或以上的受试者进行了健康检查。除了常规的危险因素外,我们还检测了HGF和PAI-1。2004-2007年间,我们还对日本长崎Uku岛的一个渔业社区的842名受试者进行了健康检查。检测脂肪细胞因子单核细胞趋化蛋白-1、纤溶酶原激活物-1和肿瘤坏死因子-α。经多元线性回归分析,调整年龄、性别和混杂因素后,单核细胞趋化蛋白-1和纤溶酶原激活物-1与胰岛素抵抗显著相关,肝细胞生长因子和肿瘤坏死因子-α也与代谢综合征的构成因素相关。肝细胞生长因子和肿瘤坏死因子-α水平与代谢综合征的积累量成正比(p&lt;0.05)。综上所述,我们的结果表明血清肝细胞生长因子和肿瘤坏死因子-α与代谢综合征密切相关。比较不同地区(农业和渔区)脂肪细胞因子和代谢综合征之间的关联强度是非常有趣的。在不久的将来,可能需要进行一次纵向流行病学调查,以澄清它们之间的地区差异。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ciroulating advanced glycation end produots(AGEs) and soluble form of receptor for AGEs(sRAGE) are independent detemlinants of serum monocyte chemoattraotant protein-1 (MCP-1) levels in patients with type 2 diabetes
循环晚期糖基化终末产物 (AGE) 和可溶性 AGE 受体 (sRAGE) 是 2 型糖尿病患者血清单核细胞趋化蛋白 1 (MCP-1) 水平的独立决定因素
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nakamura K;Yamagishi S;Adachi H;et. al.
  • 通讯作者:
    et. al.
Strong association between serum hepatocyte growth factor(HGF) and metabolic syndrome.
血清肝细胞生长因子(HGF)与代谢综合征之间有很强的相关性。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiratsuka A;Adachi H.;et. al.
  • 通讯作者:
    et. al.
Serum level of advanced glycation end-products(AGEs) is an indepondent determinant of plasminogen activator inhibitor-1(PAI-1) in nondiabetic general population
晚期糖基化终末产物(AGEs)的血清水平是非糖尿病普通人群中纤溶酶原激活剂抑制剂-1(PAI-1)的独立决定因素
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yamagishi S;Adachi H;et. al.
  • 通讯作者:
    et. al.
The association between serum MCP-1 and the metabolic syndrome.
血清 MCP-1 与代谢综合征之间的关联。
MCP-1 may be a key-factor cardio-renal syndrome. Cross-sectional Study in a general cohort
MCP-1可能是心肾综合征的关键因素。
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fukami A;Adachi H;Enomoto M;et. al.
  • 通讯作者:
    et. al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADACHI Hisashi其他文献

ADACHI Hisashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADACHI Hisashi', 18)}}的其他基金

Is resting heart rate a risk factor for the development of future metabolic syndrome?
静息心率是未来代谢综合征发生的危险因素吗?
  • 批准号:
    20590663
  • 财政年份:
    2008
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An association between atherosclerosis in the carotid ultrasonography and a novel risk factor of cardio-vascular diseases
颈动脉超声检查中动脉粥样硬化与心血管疾病新危险因素之间的关联
  • 批准号:
    16590525
  • 财政年份:
    2004
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Serum hepatocyte growth factor concentration is related to hypertension-An epidemiological study-
血清肝细胞生长因子浓度与高血压相关-流行病学研究-
  • 批准号:
    14570368
  • 财政年份:
    2002
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Association of plasma remnant-like particle cholesterol with insulin resistance in a Japanese general population
日本普通人群血浆残留样颗粒胆固醇与胰岛素抵抗的关系
  • 批准号:
    12670374
  • 财政年份:
    2000
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

miR-29: A brain homeostasis molecule for Alzheimer’s disease prevention
miR-29:一种用于预防阿尔茨海默病的大脑稳态分子
  • 批准号:
    10667151
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
Translational Multimodal Strategy for Peri-Implant Disease Prevention
种植体周围疾病预防的转化多模式策略
  • 批准号:
    10736860
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
Oral Disease Prevention Model in Long Term Care: WHO Systems Thinking Framework
长期护理中的口腔疾病预防模型:世界卫生组织系统思维框架
  • 批准号:
    10664642
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
Elucidation of lifestyle-related disease prevention effects and mechanisms of vegetables using nanofiber technology
利用纳米纤维技术阐明蔬菜的生活方式相关疾病预防效果和机制
  • 批准号:
    23H00911
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Connected Worker Disease Prevention for Construction Sector
建筑行业互联工人疾病预防
  • 批准号:
    10057475
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Collaborative R&D
Mobilising novel finance models for health promotion and disease prevention
调动新的金融模式促进健康促进和疾病预防
  • 批准号:
    10063637
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
    EU-Funded
Leveraging HIV care systems to improve cardiovascular disease prevention in the Kingdom of eSwatini
利用艾滋病毒护理系统改善埃斯瓦蒂尼王国的心血管疾病预防
  • 批准号:
    10700286
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
Building healthy communities with the dual goal of chronic disease prevention and promoting environmental sustainability
建设健康社区,实现慢性病预防和促进环境可持续发展的双重目标
  • 批准号:
    488644
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Operating Grants
Significance of biometric pulse wave screening in community residents and the elderly for disease prevention and long-term care planning.
社区居民和老年人生物特征脉搏波筛查对于疾病预防和长期护理规划的意义。
  • 批准号:
    23K10365
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development and evaluation of infectious disease prevention devices
传染病预防设备的开发与评价
  • 批准号:
    23K11899
  • 财政年份:
    2023
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了